D
Relmada Therapeutics, Inc. RLMD
$0.627 $0.0172.79% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -8.59% -35.27% -33.13% -3.10% -34.09%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -45.69% -20.75% -28.90% 1.39% -27.69%
Operating Income 45.69% 20.75% 28.90% -1.39% 27.69%
Income Before Tax 44.47% 19.56% 25.86% 1.25% 29.78%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 44.47% 19.56% 25.86% 1.25% 29.78%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 44.47% 19.56% 25.86% 1.25% 29.78%
EBIT 45.69% 20.75% 28.90% -1.39% 27.69%
EBITDA -- -- -- -- --
EPS Basic 49.52% 20.29% 26.05% 1.50% 29.95%
Normalized Basic EPS 49.59% 19.67% 28.14% -3.38% 27.79%
EPS Diluted 49.52% 20.29% 26.05% 1.50% 29.95%
Normalized Diluted EPS 49.59% 19.67% 28.14% -3.38% 27.79%
Average Basic Shares Outstanding 10.00% 0.92% 0.25% 0.25% 0.25%
Average Diluted Shares Outstanding 10.00% 0.92% 0.25% 0.25% 0.25%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --